Ruchi Gupta
Head of Biomarker Development & Operations at Alector | San Mateo, California, United States
Engage
candidates 10x faster
Enjoy unlimited access and discover candidates outside of LinkedIn
Trusted by 1.4M users from 76% of Fortune 500 companies
The most accurate data ever
CCPA Compliant
GDPR Compliant
150M
Personal Emails
200M
Work Emails
100M
Direct Dials
250M
Professional Profiles
40M
Company Profiles
Find anyone, anywhere
with ContactOut
today
Making remote or global hires?
Connecting
with key decision-makers? We can help.
- 40 emails / month
- 3 phone numbers / month
- Works on standard LinkedIn only
-
Work emails, personal emails,
mobile numbers
No credit card required
Head of Biomarker Development & Operations at Alector in July 2023 to Present
Board Member at Women in Neuroscience in July 2024 to Present
Vice President, Head of Research & Development at Pendulum Therapeutics in July 2022 to July 2023
Director, NeuroInflammation and Complement Biology at Johnson & Johnson in June 2021 to July 2022
Sr. Associate Director, Liver Diseases at Gilead Sciences in December 2018 to June 2021
Sr. Scientist at AstraZeneca in January 2018 to December 2018
Team Lead Scientist - Cardiovascular Diseases at AstraZeneca in January 2015 to January 2018
Scientist at AstraZeneca in October 2011 to December 2014
Postdoctoral Fellow at Rockefeller University in August 2008 to September 2011
PhD at Stony Brook University in December 2003 to May 2008
MS at Indian Institute of Technology, Kanpur in January 2001 to January 2003
See more
See less
Rosary Sr. Sec. School, High School, January 1983 to January 1996
The Rockefeller University, Postdoctoral Studies
The Rockefeller University, Postdoc
St Stephen College, BS, January 1999 to January 2001
Rosary Sr. Sec. School, Elementary and Middle school, January 1983 to January 1996
Indian Institute of Technology, Kanpur, Masters, January 2001 to January 2003
CAMBRIDGE FOUNDATION SENIOR SECONDARY SCHOOL, High School, January 1996 to January 1999
See more
See less
Drug Discovery, Business Development, Clinical Trials
Biomarker Development · Data Analysis · Global Drug Development · Translational Medicine · Regulatory Submissions
Teamwork
Biotechnology
Business Development
Management
Drug Development
Research and Development (R&D)
Strategy
Drug Discovery & Development Leader
Biochemistry
Protein Chemistry
Chemistry
Characterization
Science
Laboratory
Pharmaceutical Industry
Research
Biophysics
Leadership
Protein Purification
Molecular Biology
Cell Culture
Drug Discovery
Protein Expression
ELISA
Lifesciences
Cell
Assay Development
Immunology
See more
See less
Discover more about AlectorWhat is Ruchi Gupta email address?
Email Ruchi Gupta at [email protected] and [email protected]. This email is the most updated Ruchi Gupta's email found in 2026.
What is Ruchi Gupta phone number?
Ruchi Gupta phone number is 650-622-4939.
How to contact Ruchi Gupta?
To contact Ruchi Gupta send an email to [email protected] or [email protected]. If you want to call Ruchi Gupta try calling on 650-622-4939.
What company does Ruchi Gupta work for?
Ruchi Gupta works for Alector
What is Ruchi Gupta's role at Alector?
Ruchi Gupta is Head of Biomarker Development & Operations
What industry does Ruchi Gupta work in?
Ruchi Gupta works in the Research industry.
Ruchi Gupta Email Addresses
Ruchi Gupta Phone Numbers
looking for?
Find personal and work emails for over 250M professionals.
People like Ruchi Gupta
Director, Cell Biology - Fibrosis/NASH Group at Gilead Sciences
Senior Project Controller at IBA (Irving Burton Associates) at IBA (Irving Burton Associates)
Associate Director at Novartis Institutes for BioMedical Research (NIBR) at Novartis Institutes for BioMedical Research (NIBR)
Regulatory Affairs Subject Matter Expert at Biomedical Advanced Research and Development Authority BARDA/ASPR/HHS at Emergent BioSolutions
Staff Scientist at Genentech at Genentech
Principal Research Scientist at Alkermes at Vertex Pharmaceuticals
Associate Director at Bristol-Myers Squibb at Bristol Myers Squibb
at at Poseida Therapeutics, Inc.